Barclays analyst Luke Sergott maintains Thermo Fisher Scientific (NYSE:TMO) with a Overweight and lowers the price target from $660 to $625.
Barclays analyst Luke Sergott maintains Thermo Fisher Scientific (NYSE:TMO) with a Overweight and lowers the price target from $660 to $625.